Compare ZBH & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBH | DGX |
|---|---|---|
| Founded | 1927 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7B | 20.5B |
| IPO Year | N/A | 1996 |
| Metric | ZBH | DGX |
|---|---|---|
| Price | $87.78 | $182.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 21 | 13 |
| Target Price | $107.40 | ★ $196.69 |
| AVG Volume (30 Days) | ★ 2.0M | 927.2K |
| Earning Date | 02-10-2026 | 02-10-2026 |
| Dividend Yield | 1.10% | ★ 1.76% |
| EPS Growth | N/A | ★ 14.49 |
| EPS | 4.03 | ★ 8.51 |
| Revenue | $8,010,900,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $7.98 | $12.37 |
| Revenue Next Year | $5.16 | $3.54 |
| P/E Ratio | $21.71 | ★ $21.39 |
| Revenue Growth | 5.47 | ★ 13.74 |
| 52 Week Low | $85.33 | $150.14 |
| 52 Week High | $114.44 | $197.55 |
| Indicator | ZBH | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 52.91 |
| Support Level | $85.83 | $173.51 |
| Resistance Level | $89.00 | $191.07 |
| Average True Range (ATR) | 2.80 | 4.16 |
| MACD | -0.41 | 1.10 |
| Stochastic Oscillator | 20.72 | 59.41 |
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.